Robot Makeractive
Robocath
Robocath designs, develops and commercializes smart robotic solutions to treat cardiovascular diseases. Its smart connected solutions aim to enhance hand gestures and make medical procedures safer using unique bionic technology that optimizes the safety of robotic-assisted coronary angioplasty.
Rouen, FranceFounded 200951-200 employees
$73M
Total Funding
1
Robots
1
Funding Rounds
1
Investors
1.2
Hype Score
Scores
Hype1.2/10
Momentum0.2/10
Known funding rounds
Strategic
Apr 15, 2026$45M
Lead: Stereotaxis
Robots (1)
The technologies for bringing humanoids to life
Related news (4)
China's latest high-tech 'trio' fueling export growth as innovation accelerates
china.org.cn•Aug 8, 2026
China calls on US to reverse humanoid robot ban, warns of retaliation
trtworld.com•Jul 30, 2026
China aims to build humanoid robots that can work in factories - vertical version
fox19.com•Jul 29, 2026
Stereotaxis to acquire Robocath for up to $45M
therobotreport.com•Apr 15, 2026